Ajanta Pharma Ltd has received an approval from the US Food and Drug Administration (USFDA) for Fluphenazine Hydrochloride tablet, as per an exchange filing.
The dosage is in 1 mg, 2.5 mg, 5 mg and 10 mg strengths, according to an update on the drug regulator's website.
The drug is used to treat psychotic disorders such as schizophrenia.
Bombay HC Orders Disciple To Vacate Babulnath Temple Staircase Portion; Rules It Not ‘Premises Capable Of Being Let’ Under Rent Act
Mumbai News: BMC Revives Clean-Up Marshal Scheme; 246 Junior Supervisors To Patrol And Fine Littering Under 'Road Adoption Initiative'
Bombay HC Refuses Interim Relief To Mulund Society; Allows Developer To Use Additional FSI For Wing C5 Construction Under Revised DCR
Thane Shocker: 2-Year-Old Girl Injured After Being Repeatedly Bitten By Stray Dog In Diva Area; CCTV Captures Horrific Attack
